Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval. According to the National Cancer ...
Among patients with KRAS G12C mutations, candidate primary resistance mutations were detected in many patients with colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC), which may ...
AstraZeneca has added to its oncology pipeline by licensing a small-molecule KRAS inhibitor from Chinese biotech Usynova for $24 million upfront. The compound – called UA022 – targets the ...
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr. What is the Z-Tech India Ltd share price today? The Z-Tech India Ltd shares price on ...
The Company was allocated ~256 acres land by Andhra Pradesh Industrial Infrastructure Corporation (APIIC) for setting up project. It obtained pre establishment approvals from various Departments ...
CAS Key Laboratory of Bio-Inspired Materials and Interfacial Science, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing 100190, P. R. China Department of ...
Definition: Key result areas or KRAs refer to the general metrics or parameters which the organisation has fixed for a specific role. The term outlines the scope of the job profile, and captures ...
After hours: March 7 at 6:50:31 PM EST Loading Chart for CRDF ...
Article subjects are automatically applied from the ACS Subject Taxonomy and describe the scientific concepts and themes of the article. Significant advancements have recently been achieved in the ...
CM-AVM 1 is characterized by a LOF mutation in RASA1, while CM-AVM2 has the mutation in the EphB4; both activate the KRAS pathway in the wild-type state. Targeted therapies for HHT include bevacizumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results